| Analysis | Metabolite Name | Measured Value | Units | level of dysplasia | malignant transformation |
|---|---|---|---|---|---|
| Reversed phase POSITIVE ION MODE | ADENOSINE (M+H)+ | 47539 | Peak area | LGD | No |
| Reversed phase POSITIVE ION MODE | ADENOSINE (M+H)+ | 50641 | Peak area | N/A | No |
| Reversed phase POSITIVE ION MODE | ADENOSINE (M+H)+ | 404826 | Peak area | LGD | No |
| Reversed phase POSITIVE ION MODE | ADENOSINE (M+H)+ | 498722 | Peak area | N/A | No |
| Reversed phase POSITIVE ION MODE | ADENOSINE (M+H)+ | 566402 | Peak area | N/A | No |
| Reversed phase POSITIVE ION MODE | ADENOSINE (M+H)+ | Peak area | HGD | No | |
| Reversed phase POSITIVE ION MODE | ADENOSINE (M+H)+ | Peak area | HGD & PDA | yes | |
| Reversed phase POSITIVE ION MODE | ADENOSINE (M+H)+ | Peak area | HGD & PDA | Yes | |
| Reversed phase POSITIVE ION MODE | ADENOSINE (M+H)+ | Peak area | LGD | No |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|